These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20590636)

  • 1. The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels.
    Singh A; Hildebrand ME; Garcia E; Snutch TP
    Br J Pharmacol; 2010 Jul; 160(6):1464-75. PubMed ID: 20590636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of SKF96365 on the activities of K(+) channels in mouse small intestinal smooth muscle cells.
    Tanahashi Y; Wang B; Murakami Y; Unno T; Matsuyama H; Nagano H; Komori S
    J Vet Med Sci; 2016 Feb; 78(2):203-11. PubMed ID: 26498720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Englerin A Inhibits T-Type Voltage-Gated Calcium Channels at Low Micromolar Concentrations.
    Wardas B; Schneider JG; Klugbauer N; Flockerzi V; Beck A
    Mol Pharmacol; 2023 Oct; 104(4):144-153. PubMed ID: 37399325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niflumic acid blocks native and recombinant T-type channels.
    Balderas E; Ateaga-Tlecuitl R; Rivera M; Gomora JC; Darszon A
    J Cell Physiol; 2012 Jun; 227(6):2542-55. PubMed ID: 21898399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of recombinant low-voltage-activated Ca(2+) channels by the neuroprotective agent BW619C89 (Sipatrigine).
    McNaughton NC; Hainsworth AH; Green PJ; Randall AD
    Neuropharmacology; 2000 Apr; 39(7):1247-53. PubMed ID: 10760366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels.
    Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y
    Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SKF-96365 strongly inhibits voltage-gated sodium current in rat ventricular myocytes.
    Chen KH; Liu H; Yang L; Jin MW; Li GR
    Pflugers Arch; 2015 Jun; 467(6):1227-36. PubMed ID: 25017106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches.
    Xie X; Van Deusen AL; Vitko I; Babu DA; Davies LA; Huynh N; Cheng H; Yang N; Barrett PQ; Perez-Reyes E
    Assay Drug Dev Technol; 2007 Apr; 5(2):191-203. PubMed ID: 17477828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of recombinant low-voltage activated calcium channels.
    Lacinová L
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):105-11. PubMed ID: 15078185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
    Sidach SS; Mintz IM
    J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of postsynaptic T-type calcium channels to parallel fibre-Purkinje cell synaptic responses.
    Ly R; Bouvier G; Szapiro G; Prosser HM; Randall AD; Kano M; Sakimura K; Isope P; Barbour B; Feltz A
    J Physiol; 2016 Feb; 594(4):915-36. PubMed ID: 26627919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of Ca(V)3.2, a low voltage-activated Ca2+ channel cloned from human heart.
    Perchenet L; Bénardeau A; Ertel EA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):590-9. PubMed ID: 10882033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
    Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
    Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting anesthetic sensitivities of T-type Ca2+ channels of reticular thalamic neurons and recombinant Ca(v)3.3 channels.
    Joksovic PM; Brimelow BC; Murbartián J; Perez-Reyes E; Todorovic SM
    Br J Pharmacol; 2005 Jan; 144(1):59-70. PubMed ID: 15644869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.
    Belardetti F; Tringham E; Eduljee C; Jiang X; Dong H; Hendricson A; Shimizu Y; Janke DL; Parker D; Mezeyova J; Khawaja A; Pajouhesh H; Fraser RA; Arneric SP; Snutch TP
    Assay Drug Dev Technol; 2009 Jun; 7(3):266-80. PubMed ID: 19530894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of a recombinant low voltage-activated Ca(2+) channel by SB-209712.
    McNaughton NC; Warre R; Cooper DG; Nasir S; Ranson JL; Randall A
    Eur J Pharmacol; 2000 Oct; 407(1-2):53-60. PubMed ID: 11050290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.
    Ross HR; Gilmore AJ; Connor M
    Br J Pharmacol; 2009 Mar; 156(5):740-50. PubMed ID: 19226289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.